Enlivex Therapeutics Ltd. (ENLV)
NASDAQ: ENLV
· Real-Time Price · USD
1.82
0.04 (2.25%)
At close: Aug 15, 2025, 3:59 PM
1.91
4.95%
After-hours: Aug 15, 2025, 07:55 PM EDT
Enlivex Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -1.54 | -1.24 | -3.43 | -2.18 | -4.52 | -1.38 | -1.23 | -1.8 | -2.33 | -2.52 | -3.41 | -2.09 | -3.12 | -6.04 | -13.21 | -13.11 | -14.28 |
PEG Ratio | 0.05 | -0.01 | 0.14 | 0.08 | 0.08 | -0.03 | 0.09 | 0.18 | -0.14 | -0.2 | 0.06 | -0.05 | -0.03 | -0.16 | -1.12 | 1.24 | 0.25 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.03 | 1.09 | 1.34 | 0.94 | 2.79 | 1.67 | 0.76 | 1.10 | 1.33 | 1.28 | 1.24 | 1.21 | 1.32 | 1.35 | 2.05 | 1.81 | 2.02 |
P/FCF Ratio | -4.56 | -6.17 | -13.61 | -14.88 | -16.45 | -9.98 | -5.37 | -6.92 | -11.34 | -9.81 | -10.04 | -6.55 | -24.33 | -15.01 | -41.87 | -34.6 | -72.73 |
P/OCF Ratio | -4.59 | -6.22 | -13.66 | -15.01 | -16.61 | -9.99 | -5.4 | -6.96 | -11.65 | -15.06 | -11.86 | -8.96 | -31.41 | -17.36 | -43.07 | -36.94 | -78.1 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.12 | 0.10 | 0.09 | 0.09 | 0.08 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
Quick Ratio | 7.20 | 6.84 | 9.67 | 10.02 | 7.86 | 5.61 | 7.62 | 6.52 | 7.17 | 7.74 | 8.86 | 15.44 | 13.81 | 18.32 | 19.08 | 20.29 | 19.29 |
Current Ratio | 7.20 | 6.84 | 9.71 | 10.06 | 7.86 | 5.57 | 7.34 | 6.17 | 6.89 | 7.92 | 13.08 | 15.44 | 13.81 | 18.32 | 19.08 | 20.29 | 19.11 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -15.59 | n/a | -101.38 | -1.45 | -3.52 | n/a | n/a | n/a | n/a |
Return on Equity | -0.17 | -0.22 | -0.1 | -0.11 | -0.15 | -0.3 | -0.15 | -0.15 | -0.14 | -0.13 | -0.09 | -0.14 | -0.11 | -0.06 | -0.04 | -0.03 | -0.04 |
Return on Assets | -0.14 | -0.19 | -0.09 | -0.1 | -0.13 | -0.25 | -0.13 | -0.13 | -0.12 | -0.11 | -0.08 | -0.13 | -0.09 | -0.05 | -0.03 | -0.03 | -0.03 |
Return on Invested Capital | -0.17 | -0.23 | -0.11 | -0.1 | -0.14 | -0.2 | -0.13 | -0.14 | -0.12 | -0.13 | -0.08 | -0.08 | -0.08 | -0.09 | -0.04 | -0.04 | -0.04 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |